EGF is a chemoattractant for monocytes, implicated with the recruitment of monocytes at the sites of inflammation [50], whereas urine epidermal growth factor (EGF) levels might serve as a potential biomarker of response to treatment in patients with Lupus Nephritis (LN) [51]. Here, EGF is linked to lobular neoplasia.